Description

Iratumumab CAS NO 640735-09-7 is a high-purity monoclonal antibody for research and pharmaceutical development. This compound is critical for advancing targeted cancer therapies and immunological research. It is primarily utilized by biotechnology firms, pharmaceutical R&D departments, and academic research institutions focused on oncology and immunotherapy.

Application

• Pharmaceutical R&D: Key intermediate in the development of novel monoclonal antibody-based cancer therapeutics.
• Biomarker Research: Used in immunological assays to study specific antigen-antibody interactions and signaling pathways.
• Preclinical Studies: Essential for in vitro and in vivo testing to evaluate efficacy and mechanism of action in disease models.
• Process Development: Serves as a reference standard in the optimization of upstream and downstream biomanufacturing processes.
• Diagnostic Reagent Development: Employed in the creation of sensitive and specific diagnostic kits for disease detection.

Basic Information

Item	Details
Product Name	Iratumumab
CAS No.	640735-09-7
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	Anti-CD20 Monoclonal Antibody; Iratumumab (USAN); UNII-C6V7V5228S; Monoclonal Antibody CD20; Therapeutic Antibody CD20; B-Lymphocyte Antigen CD20 Antibody; C6V7V5228S
EINECS	Contact for details

Quality Control

Our Iratumumab is produced under stringent quality management systems. Each batch undergoes comprehensive analytical testing, including purity assessment by HPLC, identity confirmation, and biological activity assays to ensure it meets the high standards required for research and development. Certificates of Analysis (COA) documenting all critical quality attributes are available upon request.

Storage

Preserve in a tightly closed container, protected from light. For long-term stability, store at -20°C or below. Avoid repeated freeze-thaw cycles. The product should be handled under appropriate conditions to maintain its biological integrity.

Specification

Item	Specification
Appearance	White to off-white lyophilized powder or clear solution
Identification (HPLC/LC-MS)	Conforms to reference standard
Purity (SDS-PAGE)	≥ 95%
Purity (SEC-HPLC)	≥ 98.0% (Monomer)
Protein Content	≥ 1.0 mg/mL (or as per COA)
Endotoxin	< 1.0 EU/mg
Biological Activity	Contact for details

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.